immunoassays
(2)
Abcam Turned the Antibody Catalog Into a Quality-Control Machine
The Cambridge company began with one postdoc’s bad antibody problem. Twenty-eight years later, its real product is not merely a vial - it is the confidence that a costly experiment will not have to be run twice.
Kim Kelderman
Kim Kelderman is the President and CEO of Bio-Techne Corporation, a global life science tools and diagnostics company headquartered in Minneapolis, Minnesota. With over 30 years of healthcare and life sciences experience, Kelderman rose through the ranks at Bio-Techne after joining in 2018 to lead the Diagnostics and Genomics segment, where he doubled the spatial biology business and commercialized the ExoDx Prostate test. A native of the Netherlands educated at Hogeschool Heerlen and Columbia Business School, he previously held executive roles at Thermo Fisher Scientific and Becton Dickinson. He became CEO on February 1, 2024, succeeding Chuck Kummeth.